BP102
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for BP102, covering 2021-07-23 to 2025-07-11. Get the full timeline:
Most recent: Clinical Trial Update: An Explorative Study of HRS-2189 Combined With Adebrelimab and BP102 for Metastatic Colorectal Cancer [Phase 2]